Johnson & Johnson Halts COVID-19 Vaccine Study After Participant Comes Down With ‘Unexplained Illness’
The clinical trial involves 60,000 patients.
Chandan Khanna/Getty
Johnson & Johnson hit pause on its clinical trial for a coronavirus vaccine after a study participant came down with an “unexplained illness,” the company told STAT. “We must respect this participant’s privacy. We’re also learning more about this participant’s illness, and it’s important to have all the facts before we share additional information,” the health-care behemoth added. A document obtained by STAT informed researchers that people would no longer be able to enroll for the clinical trial—which involves 60,000 patients—online, and that a committee that monitors patient safety in the study would meet to assess the situation. Johnson & Johnson stressed to STAT that pauses are common. “If we do a study of 60,000 people, that is a small village,” a source told the outlet. “In a small village there are a lot of medical events that happen.”
See more of our coverage in your search results.
Got a tip? Send it to The Daily Beast here.
Register below to read this article for free or subscribe
to unlock unlimited access to The Daily Beast.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Already have an account? Sign In
Looks like you already have a subscription!
You're all set!
Thanks for subscribing.